Human Genome Sciences Appoints David P. Southwell to Its Board of Directors

Posted on: Thursday, 24 July 2008, 09:01 CDT ROCKVILLE, Md., July 24 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. today announced that David P. Southwell has been appointed to the HGS Board of Directors. He will also serve as a member of the Company's Audit Committee. Until recently, Mr. Southwell was at Sepracor, Inc., a research-based pharmaceutical company, where he served as Executive Vice President and Chief Financial Officer, and also had responsibility for Corporate Planning, Development and Licensing. (Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO "David Southwell brings more than twenty years of experience and significant accomplishment to HGS in financial strategy, planning and business development," said H. Thomas Watkins, President and Chief Executive Officer, HGS. "We look forward to... [read full story]